Free Trial

Neuronetics (STIM) News Today

Neuronetics logo
$4.12 +0.04 (+0.96%)
As of 12:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Neuronetics, Inc. stock logo
Neuronetics, Inc. (NASDAQ:STIM) Sees Significant Increase in Short Interest
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 1,990,000 shares, an increase of 24.4% from the February 13th total of 1,600,000 shares. Based on an average trading volume of 1,330,000 shares, the short-interest ratio is presently 1.5 days. Currently, 7.3% of the shares of the company are sold short.
Neuronetics, Inc. stock logo
William Blair Forecasts Increased Earnings for Neuronetics
Neuronetics, Inc. (NASDAQ:STIM - Free Report) - Equities research analysts at William Blair boosted their Q1 2025 EPS estimates for Neuronetics in a research report issued to clients and investors on Wednesday, March 5th. William Blair analyst M. Andrew now forecasts that the company will post ea
Neuronetics, Inc. stock logo
Neuronetics (NASDAQ:STIM) Given New $8.00 Price Target at Canaccord Genuity Group
Canaccord Genuity Group raised their target price on Neuronetics from $5.00 to $8.00 and gave the company a "buy" rating in a report on Wednesday.
Neuronetics price target raised to $8 from $5 at Canaccord
Neuronetics price target raised to $7 from $3 at Citizens JMP
Neuronetics reports Q4 EPS (33c), consensus (24c)
Neuronetics, Inc. stock logo
Neuronetics (NASDAQ:STIM) Issues Earnings Results, Misses Expectations By $0.07 EPS
Neuronetics (NASDAQ:STIM - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.07). Neuronetics had a negative net margin of 50.09% and a negative return on equity of 141.24%.
Neuronetics, Inc. stock logo
Neuronetics (STIM) Projected to Post Quarterly Earnings on Tuesday
Neuronetics (NASDAQ:STIM) will be releasing earnings before the market opens on Tuesday, March 4. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=669079)
Neuronetics, Inc. stock logo
Insider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 17,307 Shares of Stock
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 17,307 shares of the firm's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $4.11, for a total value of $71,131.77. Following the completion of the transaction, the chief financial officer now owns 454,420 shares in the company, valued at approximately $1,867,666.20. This trade represents a 3.67 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Neuronetics, Inc. stock logo
Insider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 10,845 Shares of Stock
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 10,845 shares of the stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $3.83, for a total transaction of $41,536.35. Following the transaction, the chief financial officer now owns 471,727 shares of the company's stock, valued at $1,806,714.41. This trade represents a 2.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Neuronetics, Inc. stock logo
Neuronetics, Inc. (NASDAQ:STIM) EVP Sells $46,630.25 in Stock
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) EVP William Andrew Macan sold 12,175 shares of the company's stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $3.83, for a total value of $46,630.25. Following the sale, the executive vice president now owns 388,647 shares of the company's stock, valued at $1,488,518.01. The trade was a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Neuronetics, Inc. stock logo
Stephen Furlong Sells 14,836 Shares of Neuronetics, Inc. (NASDAQ:STIM) Stock
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 14,836 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $3.28, for a total transaction of $48,662.08. Following the completion of the transaction, the chief financial officer now directly owns 482,572 shares in the company, valued at approximately $1,582,836.16. The trade was a 2.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Neuronetics, Inc. stock logo
Insider Selling: Neuronetics, Inc. (NASDAQ:STIM) CEO Sells 40,992 Shares of Stock
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) CEO Keith J. Sullivan sold 40,992 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $3.28, for a total transaction of $134,453.76. Following the completion of the sale, the chief executive officer now owns 1,283,362 shares of the company's stock, valued at $4,209,427.36. This trade represents a 3.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Neuronetics Shares Drop After $18M Offering Priced
Neuronetics prices 8M shares at $2.25 in underwritten public offering
Neuronetics announces common stock offering, no amount given
Neuronetics, Inc. stock logo
Neuronetics, Inc. (NASDAQ:STIM) Short Interest Update
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 312,900 shares, a drop of 35.8% from the December 31st total of 487,400 shares. Currently, 2.0% of the shares of the company are short sold. Based on an average trading volume of 413,300 shares, the short-interest ratio is presently 0.8 days.
Neuronetics, Inc. stock logo
Neuronetics, Inc. (NASDAQ:STIM) Sees Significant Drop in Short Interest
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 312,900 shares, a decline of 35.8% from the December 15th total of 487,400 shares. Currently, 2.0% of the shares of the stock are sold short. Based on an average trading volume of 413,300 shares, the short-interest ratio is presently 0.8 days.
Neuronetics sees FY25 revenue $145M-$155M
Remove Ads
Get Neuronetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.

STIM Media Mentions By Week

STIM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

STIM
News Sentiment

0.22

0.82

Average
Medical
News Sentiment

STIM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

STIM Articles
This Week

4

2

STIM Articles
Average Week

Remove Ads
Get Neuronetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:STIM) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners